Mechanisms and Management of Itch in Dry Skin

Persistent itch, extending beyond a span of six weeks, frequently accompanies pathological dry skin-related pathologies, notably encompassing xerosis, atopic dermatitis, and hepatic or renal disorders. The genesis of itch within the context of dry skin is largely attributed to a deterioration in the functionality of the skin barrier. A comprehensive research from Chiba, Japan, concisely encapsulates the contemporary understanding of the pathogenesis behind this phenomenon, while also delineating therapeutic strategies aimed at alleviating itch in dry skin contexts.
The fundamental understanding of dry skin is a compromised skin barrier, which can be instigated by an interplay of environmental factors encompassing sun exposure, temperature, humidity, and genetic predispositions. Clinically, the presence of chronic itch is also closely connected with mood disturbances, most notably anxiety and depression, primarily within the demographical realm of dermatological patients.
Numerous investigations have been dedicated to the management of this condition, suggesting an array of approaches. Among these, second-generation H1-antihistamines (bepotastine) emerge as a viable option. Simultaneously, the utility of emollients such as hydrophilic petrolatum and heparinoid cream, and UV-based therapies like PUVA and narrowband-ultraviolet B, have garnered considerable attention. An expansive spectrum of alternative treatment modalities has also been used, encompassing opioids, neurotropin, phospholipids, antioxidants, and collagen tripeptide. Recent studies based on animal experimentation, revealed that the application of film dressings, conventionally employed for wound management to foster an optimal moist environment while acting as a protective shield against contamination, exhibits the capacity to ameliorate epidermal hyperinnervation and alloknesis. For a deeper dive into the intricacies, delve into the provided link for additional insights!